Article Text

Download PDFPDF
Prosthetic hip infection due to Campylobacter jejuni
  1. Andrew Joseph Simms1,
  2. Takaaki Kobayashi2,
  3. Patrick V Schwartzhoff3 and
  4. Poorani Sekar2
  1. 1Internal Medicine, Infectious Diseases, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
  2. 2Internal Medicine, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
  3. 3Internal Medicine, Carver College of Medicine, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
  1. Correspondence to Dr Andrew Joseph Simms; andrew-simms{at}uiowa.edu

Abstract

A woman in her 60s with a left hip prosthesis was presented with left hip pain and fever. She had an elevated white blood cell count and inflammatory markers. Synovial fluid Gram stain demonstrated curved Gram-negative rods identified as Campylobacter jejuni. The patient initially refused surgery and after 3 months underwent one-stage exchange after which she was treated with 12 weeks of levofloxacin. Her inflammatory markers normalised and she was clinically doing well at her 6-month follow-up. C. jejuni is a rare cause of prosthetic joint infection and should be included in the differential diagnosis when a patient has risk factors even without significant preceding gastrointestinal symptoms. Per most recent Infectious Diseases Society of America guidelines, treatment after one-stage revision includes 4–6 weeks of intravenous antimicrobials followed by possible oral suppression therapy, while the European guidelines recommend 12 weeks of orally bioavailable antibiotics.

  • hip implants
  • infectious diseases
  • bone and joint infections

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AS wrote the first draft of the manuscript. PVS, TK and PS critically reviewed and revised the manuscript. All authors read and approved the final paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.